Evidence map›Paper›PMID 35635291›Full record

ArticleJournal of cell science2022

Unconventional tonicity-regulated nuclear trafficking of NFAT5 mediated by KPNB1, XPOT and RUVBL2.

Chris Y Cheung, Ting-Ting Huang, Ning Chow, Shuqi Zhang, Yanxiang Zhao, Mary P Chau, Wing Cheung Chan, Catherine C L Wong, Daniela Boassa, Sebastien Phan and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Chris Y CheungDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.ORCID 0000-0003-0840-4117
Ting-Ting HuangDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.
Ning ChowDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.ORCID 0000-0002-6374-4221
Shuqi ZhangDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.
Yanxiang ZhaoDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.
Mary P ChauDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.
Wing Cheung ChanDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.
Catherine C L WongCenter for Precision Medicine Multi-Omics Research , Health Science Center, Peking University, China Clinical Laboratory Department, The Cancer Hospital of the University of Chinese Academy of Sciences, 102206, Beijing, China.
Daniela BoassaDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.ORCID 0000-0003-4631-4139
Sebastien PhanDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.
Mark H EllismanDepartment of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.
John R YatesDepartment of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0001-5267-1672
SongXiao XuThe Clinical Laboratory Department, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Hangzhou, 310000, Zhejiang, China.ORCID 0000-0001-6894-660X
Zicheng YuDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.
Yajing ZhangDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.
Rui ZhangDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.ORCID 0000-0003-4343-8750
Ling Ling NgDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.
Ben C B KoDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.ORCID 0000-0003-2027-5899
Hong Kong Polytechnic University · HKUniversity of California San Diego · USPeking University · CNScripps Research Institute · USZhejiang Cancer Hospital · CN

Funding

IVEM and Image Analysis ResourceP41GM103412 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2012 to 2019
$17.9M
New Probe and Methods for Correlated LM & EMR01GM086197 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, STEPHEN ROY, BOASSA, DANIELA · 2008 to 2020
$8.3M
National Center for Microscopy and Imaging Research: A BRAIN Technology Integration and Dissemination ResourceU24NS120055 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2021 to 2025
$5.4M
Health and Medical Research Fund 08191866Hong Kong Government 15106417Hong Kong Government C5012-15EHong Kong Government R5050-18Hong Kong Polytechnic University P0009343NIGMS NIH HHS P41 GM103412NIGMS NIH HHS R01 GM086197NIH HHS 08191866NIH HHS R01GM086197NINDS NIH HHS U24 NS120055Research Grants Council, University Grants Committee 15106417
6 · The paper itself

Abstract

NFAT5 is the only known mammalian tonicity-responsive transcription factor with an essential role in cellular adaptation to hypertonic stress. It is also implicated in diverse physiological and pathological processes. NFAT5 activity is tightly regulated by extracellular tonicity, but the underlying mechanisms remain elusive. Here, we demonstrate that NFAT5 enters the nucleus via the nuclear pore complex. We found that NFAT5 utilizes a unique nuclear localization signal (NFAT5-NLS) for nuclear import. siRNA screening revealed that only karyopherin β1 (KPNB1), but not karyopherin α, is responsible for the nuclear import of NFAT5 via direct interaction with the NFAT5-NLS. Proteomics analysis and siRNA screening further revealed that nuclear export of NFAT5 under hypotonicity is driven by exportin-T (XPOT), where the process requires RuvB-like AAA-type ATPase 2 (RUVBL2) as an indispensable chaperone. Our findings have identified an unconventional tonicity-dependent nucleocytoplasmic trafficking pathway for NFAT5 that represents a critical step in orchestrating rapid cellular adaptation to change in extracellular tonicity. These findings offer an opportunity for the development of novel NFAT5 targeting strategies that are potentially useful for the treatment of diseases associated with NFAT5 dysregulation.

Indexed as

Cell NucleusKaryopherinsActive Transport, Cell NucleusAnimalsATPases Associated with Diverse Cellular Activitiesbeta KaryopherinsCarrier ProteinsDNA HelicasesHumansMammalsNuclear Localization SignalsNucleocytoplasmic Transport ProteinsRNA, Small InterferingTranscription FactorsATPases Associated with Diverse Cellular Activitiesbeta KaryopherinsCarrier ProteinsDNA HelicasesKaryopherinsKPNB1 protein, humanNFAT5 protein, humanNuclear Localization SignalsNucleocytoplasmic Transport ProteinsRNA, Small InterferingRUVBL2 protein, humanTranscription FactorsXPOT protein, humanExportin-TImportinNFAT5Nucleocytoplasmic traffickingRUVBL2

Identifiers

PMID35635291
PMCPMC9377714
OpenAlexW4281776404

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.